Improved life expectancy of people living with HIV: who is left behind?
作者信息
Katz Ingrid T, Maughan-Brown Brendan
机构信息
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Massachusetts General Hospital, Center for Global Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Southern Africa Labour and Development Research Unit, University of Cape Town, South Africa.
出版信息
Lancet HIV. 2017 Aug;4(8):e324-e326. doi: 10.1016/S2352-3018(17)30086-3. Epub 2017 May 10.
Abstract
摘要
相似文献
1
Improved life expectancy of people living with HIV: who is left behind?感染艾滋病毒者预期寿命的提高：哪些人被落下了？
Lancet HIV. 2017 Aug;4(8):e324-e326. doi: 10.1016/S2352-3018(17)30086-3. Epub 2017 May 10.
2
Life expectancy living with HIV: recent estimates and future implications.预期寿命与 HIV 共存：最新估计及未来影响。
Curr Opin Infect Dis. 2013 Feb;26(1):17-25. doi: 10.1097/QCO.0b013e32835ba6b1.
3
Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.开始联合抗逆转录病毒治疗后HIV阳性者的预期寿命：一项荟萃分析。
HIV Med. 2017 Apr;18(4):256-266. doi: 10.1111/hiv.12421. Epub 2016 Aug 31.
4
Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991-2012).乌干达农村抗逆转录病毒治疗时代的成人预期寿命趋势（1991 - 2012年）
AIDS. 2016 Jan 28;30(3):487-93. doi: 10.1097/QAD.0000000000000930.
5
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population.全球接受抗逆转录病毒治疗的HIV阳性成年人的预期寿命趋势：与普通人群的比较。
Curr Opin HIV AIDS. 2016 Sep;11(5):492-500. doi: 10.1097/COH.0000000000000298.
6
7
[HIV infection, from a death sentence to a chronic disease].[从死刑判决到慢性病：HIV感染]
Soins. 2019 Apr;64(834):14-19. doi: 10.1016/j.soin.2019.02.002.
8
Life expectancy in Africa: back to the future?非洲的预期寿命：回归未来？
Ann Intern Med. 2011 Aug 16;155(4):265-6. doi: 10.7326/0003-4819-155-4-201108160-00359. Epub 2011 Jul 18.
9
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.瑞士HIV阳性者的预期寿命：与普通人群的匹配比较。
AIDS. 2017 Jan 28;31(3):427-436. doi: 10.1097/QAD.0000000000001335.
10
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.在拉丁美洲和加勒比地区，接受抗逆转录病毒疗法的 HIV 感染者的预期寿命增益：一项多地点回顾性队列研究。
Lancet HIV. 2021 May;8(5):e266-e273. doi: 10.1016/S2352-3018(20)30358-1. Epub 2021 Apr 20.
引用本文的文献
1
Perception of healthcare professionals about the knowledge of people living with HIV regarding clinical trials for HIV-related cancers.医疗保健专业人员对艾滋病毒感染者关于艾滋病毒相关癌症临床试验知识的认知。
BMC Public Health. 2025 Jul 3;25(1):2377. doi: 10.1186/s12889-025-23137-w.
2
Motivations for Starting and Stopping PrEP: Experiences of Adolescent Girls and Young Women in the HPTN 082 Trial.开始和停止暴露前预防的动机：HPTN 082试验中少女和年轻女性的经历
AIDS Behav. 2025 Jun 3. doi: 10.1007/s10461-025-04703-0.
3
What services, interventions and support are available for People with HIV in England to manage their overall health and wellbeing? A scoping review.在英格兰，感染艾滋病毒的人可以获得哪些服务、干预措施和支持来管理他们的整体健康和福祉？一项范围综述。
HIV Med. 2025 Jul;26(7):1004-1033. doi: 10.1111/hiv.70041. Epub 2025 May 7.
4
SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes.溶质载体家族38成员9（SLC38A9）直接参与了由反式激活转录蛋白（Tat）诱导的星形胶质细胞内溶酶体功能障碍和衰老过程。
Life Sci Alliance. 2025 May 5;8(7). doi: 10.26508/lsa.202503231. Print 2025 Jul.
5
The impact of childhood maltreatment, HIV status, and their interaction on mental health outcomes and markers of systemic inflammation in women.童年期虐待、艾滋病毒感染状况及其相互作用对女性心理健康结果和全身炎症标志物的影响。
Biol Sex Differ. 2025 Mar 28;16(1):21. doi: 10.1186/s13293-025-00704-9.
6
Applying population-specific incidence prevalence ratio benchmarks to monitor the Australian HIV epidemic: an epidemiological analysis.应用特定人群发病率与患病率比值基准监测澳大利亚的艾滋病毒疫情：一项流行病学分析。
J Int AIDS Soc. 2024 Dec;27(12):e26399. doi: 10.1002/jia2.26399.
7
Antiretroviral Therapy during Long-term Surgical Care: 'Exploring Difficult Cases in HIV Clinics' of the Korean Society for AIDS Conference in 2023.长期外科护理期间的抗逆转录病毒疗法：2023年韩国艾滋病学会会议“探索HIV诊所中的疑难病例”
Infect Chemother. 2024 Sep;56(3):287-299. doi: 10.3947/ic.2024.0052. Epub 2024 Aug 1.
8
The Association between IL-1β and IL-18 Levels, Gut Barrier Disruption, and Monocyte Activation during Chronic Simian Immunodeficiency Virus Infection and Long-Term Suppressive Antiretroviral Therapy.在慢性猴免疫缺陷病毒感染和长期抑制性抗逆转录病毒治疗期间，IL-1β 和 IL-18 水平、肠道屏障破坏和单核细胞活化之间的关联。
Int J Mol Sci. 2024 Aug 9;25(16):8702. doi: 10.3390/ijms25168702.
9
Challenges in managing HIV and non-communicable diseases and health workers' perception regarding integrated management of non-communicable diseases during routine HIV care in South Central Uganda: A qualitative study.乌干达中南地区艾滋病毒和非传染性疾病管理面临的挑战以及卫生工作者对常规艾滋病毒护理中实施非传染性疾病综合管理的看法：一项定性研究。
PLoS One. 2024 Aug 20;19(8):e0302290. doi: 10.1371/journal.pone.0302290. eCollection 2024.
10
Prevalence and predictors of HIV-related disability among people living with HIV in Nigeria.尼日利亚艾滋病病毒感染者中与艾滋病相关残疾的患病率及预测因素
S Afr J Physiother. 2024 Jul 30;80(1):2001. doi: 10.4102/sajp.v80i1.2001. eCollection 2024.
本文引用的文献
1
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.1996 年至 2013 年开始抗逆转录病毒治疗的 HIV 阳性患者的生存情况：队列研究的协作分析。
Lancet HIV. 2017 Aug;4(8):e349-e356. doi: 10.1016/S2352-3018(17)30066-8. Epub 2017 May 10.
2
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.在非洲开展的早期抗逆转录病毒治疗和异烟肼预防治疗试验。
N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.
3
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.早期无症状HIV感染中抗逆转录病毒治疗的启动
N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.
4
Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa.南非农村地区一项基于家庭的艾滋病毒咨询与检测干预措施后的护理联系情况。
J Int AIDS Soc. 2015 Jun 8;18(1):19843. doi: 10.7448/IAS.18.1.19843. eCollection 2015.
5
Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.了解南非索韦托接受艾滋病毒检测的成年人中拒绝治疗的情况：一项定性研究。
AIDS Behav. 2015 Apr;19(4):704-14. doi: 10.1007/s10461-014-0920-y.
6
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.在南非、欧洲或北美开始接受抗逆转录病毒治疗的HIV-1感染患者的死亡率：前瞻性研究的协作分析
PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.
7
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.弥合差距：美国和加拿大接受治疗的 HIV 阳性个体的预期寿命增加。
PLoS One. 2013 Dec 18;8(12):e81355. doi: 10.1371/journal.pone.0081355. eCollection 2013.
8
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.南非开始抗逆转录病毒治疗的成年人的预期寿命：队列研究的协作分析。
PLoS Med. 2013;10(4):e1001418. doi: 10.1371/journal.pmed.1001418. Epub 2013 Apr 9.
9
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.艾滋病病毒抗逆转录病毒治疗衔接的风险因素、障碍和促进因素：系统评价。
AIDS. 2012 Oct 23;26(16):2059-67. doi: 10.1097/QAD.0b013e3283578b9b.
10
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.低收入国家接受联合抗逆转录病毒疗法者的预期寿命：乌干达的一项队列分析。
Ann Intern Med. 2011 Aug 16;155(4):209-16. doi: 10.7326/0003-4819-155-4-201108160-00358. Epub 2011 Jul 18.
Zotero 插件